Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion type Assertion NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_head.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion description "[In the group of patients with AOD, those who were positive for DRB1*16 specificity have a statistically significant chance to develop EN, as opposed to those who are positive for DRB1*15 specificity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_provenance.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion evidence source_evidence_literature NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_provenance.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion SIO_000772 17767551 NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_provenance.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion wasDerivedFrom befree-20150227 NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_provenance.
- NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_assertion wasGeneratedBy ECO_0000203 NP454822.RAXHi_V86fVKdIG0HADkodc-FJRr0-RNwFn_mKKLwkj7U130_provenance.